SEC Form 4 · Rule 10b5-1 trading plans
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
- 17Trades filed under a plan
- 0Plan adoption dates stated
- 7Quarterly results prints on file
- 0Trades in the days before a print
In the 2025 filing year, ARROWHEAD PHARMACEUTICALS, INC. filed 9 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 5 reporting owners, covering 17 transactions filed under those plans and 467,559 shares. None carries the SEC's own AFF10B5ONE adoption flag; each of the 9 names a plan in a footnote. 7 results prints are on file in the same window, which is what makes the interval below measurable.
Trades filed under a plan in ARROWHEAD PHARMACEUTICALS, INC. 17
- Anzalone Christopher Richard — 2025-01-02 · S · 11,520 shares
- Hamilton James C — 2025-01-06 · S · 21,758 shares
- Hamilton James C — 2025-01-06 · S · 10,971 shares
- Myszkowski Kenneth Allen — 2025-01-06 · S · 17,765 shares
- Myszkowski Kenneth Allen — 2025-01-06 · S · 9,402 shares
- O'Brien Patrick — 2025-01-06 · S · 19,658 shares
- O'Brien Patrick — 2025-01-06 · S · 9,526 shares
- Myszkowski Kenneth Allen — 2025-01-07 · S · 8,000 shares
- Myszkowski Kenneth Allen — 2025-01-07 · S · 10,000 shares
- O'Brien Patrick — 2025-01-07 · S · 8,000 shares
- OLUKOTUN ADEOYE Y — 2025-01-23 · S · 959 shares
- Anzalone Christopher Richard — 2025-03-03 · S · 166,667 shares
Plan adoption dates stated in ARROWHEAD PHARMACEUTICALS, INC. 0
Quarterly results prints on file in ARROWHEAD PHARMACEUTICALS, INC. 7
- 2025-02-10
- 2025-05-12
- 2025-08-07
- 2025-11-25
- 2026-02-05
- 2026-05-07
- 2026-08-04
Trades in the days before a print in ARROWHEAD PHARMACEUTICALS, INC. 0
- 18 days before the 2025-02-10 print — 2025-01-23 · S · OLUKOTUN ADEOYE Y · 959 shares
- 34 days before the 2025-02-10 print — 2025-01-07 · S · Myszkowski Kenneth Allen · 8,000 shares
- 34 days before the 2025-02-10 print — 2025-01-07 · S · Myszkowski Kenneth Allen · 10,000 shares
- 34 days before the 2025-02-10 print — 2025-01-07 · S · O'Brien Patrick · 8,000 shares
- 35 days before the 2025-02-10 print — 2025-01-06 · S · Hamilton James C · 21,758 shares
- 35 days before the 2025-02-10 print — 2025-01-06 · S · Hamilton James C · 10,971 shares
- 35 days before the 2025-02-10 print — 2025-01-06 · S · Myszkowski Kenneth Allen · 17,765 shares
- 35 days before the 2025-02-10 print — 2025-01-06 · S · Myszkowski Kenneth Allen · 9,402 shares
- 35 days before the 2025-02-10 print — 2025-01-06 · S · O'Brien Patrick · 19,658 shares
- 35 days before the 2025-02-10 print — 2025-01-06 · S · O'Brien Patrick · 9,526 shares
- 39 days before the 2025-02-10 print — 2025-01-02 · S · Anzalone Christopher Richard · 11,520 shares
- 69 days before the 2025-05-12 print — 2025-03-04 · S · Anzalone Christopher Richard · 133,333 shares
Interval to the next reported results date
For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.
- 0Within 5 days of a print
- 0Within 10 days of a print
- 18Shortest interval, in days
- 0Trades with no later print on file
Reported results dates on file
- 2025-02-10
- 2025-05-12
- 2025-08-07
- 2025-11-25
- 2026-02-05
- 2026-05-07
- 2026-08-04
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 1
- FMC CORP 2
- ELI LILLY & Co 4
- ABEONA THERAPEUTICS INC. 2
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 12
- Lifevantage Corp 1
- IONIS PHARMACEUTICALS INC 29
- VERTEX PHARMACEUTICALS INC / MA 22
- GILEAD SCIENCES, INC. 17
Order the document
Every company with plan records →
Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.